Standards; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites;
應(yīng)用:
4-[8-(2,1,3-Benzoxadiazol-5-yl)-1,7-naphthyridin-6-yl]benzoic Acid is a phosphodiesterase PDE4D inhibitor that functions as an anti-prostrate cancer therapy in both in vitro and in vivo models. Also functions as phosphodiesterase 4 inhibitor with anti-inflammatory activity with the potential for the treatment of airway inflammatory conditions such as asthma and chronic obstructive pulmonary diseases.